2 recruiting, 1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Clonal Hematopoiesis of Indeterminate Potential (CHIP): new trials by email Literature Review of Clonal Hematopoiesis of Indeterminate Potential (CHIP) trials Research Report on Clonal Hematopoiesis of Indeterminate Potential (CHIP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction Clonal hematopoiesis assessment and cardiac magnetic resonance imaging - ST-elevation Myocardial Infarction (STEMI), Clonal Hematopoiesis of Indeterminate Potential (CHIP) | Recruiting | Medical University Innsbruck | 350 | 2026-06-20 | 2026-10-09 | |
| Clonal Hematopoiesis Chemotherapy and Radiation Effects Study Samples - Lung Cancer (Diagnosis), Osteochondroma | Recruiting | Dana-Farber Cancer Institute | 5000 | 2025-04-04 | 2026-06-30 | |
| A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) MAS825, MAS825 Placebo, DFV890 - Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP) | Phase 2 | Completed | Novartis Pharmaceuticals | 31 | 2024-02-15 | 2026-04-09 |
Adenocarcinoma Of Esophagus (1) · Breast Neoplasms (1) · Colonic Neoplasms (1) · Coronary Disease (1) · Disease (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Nevus, Epithelioid and Spindle Cell (1) · Osteochondroma (1) · ST Elevation Myocardial Infarction (1) · Sarcoma (1) · Stomach Neoplasms (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Myocardial Ischemia (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Breast Diseases (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Sampling Studies (1)
Dana-Farber Cancer Institute (1) · Medical University Innsbruck (1) · Novartis Pharmaceuticals (1)
United States (2) · Austria (1) · Canada (1) · Germany (1)
2023 (1)